Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.523 USD | +4.10% | -0.73% | -4.62% |
22/03 | Sangamo Therapeutics Prices $24 Million Registered Direct Offering | MT |
14/03 | Sangamo Therapeutics Pushes Neurology Programs Toward Clinical Development, Wedbush Says | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.62% | 104M | |
+2.91% | 108B | |
+10.26% | 105B | |
+1.57% | 23.46B | |
-12.22% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.74% | 17.19B | |
+6.38% | 13.99B | |
+36.81% | 12.53B |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- Wells Fargo Downgrades Sangamo Therapeutics to Equal-Weight From Overweight, Price Target is $1